This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vicore Pharma Ab. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Nadia Nasser Petersen: Innovator in Pharmaceutical Compounds
Introduction
Nadia Nasser Petersen is a prominent inventor based in Uppsala, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target autoimmune and fibrotic diseases. Her work is crucial in advancing treatments for conditions such as idiopathic pulmonary fibrosis and sarcoidosis.
Latest Patents
Nadia holds a patent for selective angiotensin II compounds. This patent includes pharmaceutical compounds of formula I, wherein R, R, R, R, R, R, Y, Y, Y, X, and Z have specific meanings as described in the patent documentation. These compounds are designed to be effective in treating various autoimmune and fibrotic diseases.
Career Highlights
Nadia is currently associated with Vicore Pharma AB, where she continues to innovate and develop new pharmaceutical solutions. Her expertise and dedication to her work have positioned her as a key player in her field.
Collaborations
Nadia has collaborated with notable colleagues, including Anders Rudolf Hallberg and Mats Larhed. These partnerships have further enhanced her research and development efforts.
Conclusion
Nadia Nasser Petersen is a trailblazer in the pharmaceutical industry, with her innovative work paving the way for new treatments for serious health conditions. Her contributions are invaluable to the ongoing fight against autoimmune and fibrotic diseases.